Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 344 (D.Del. Jun. 10, 2024)
Cite Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 344 (D.Del. Jun. 10, 2024)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 79 (S.D.N.Y. Aug. 4, 2023)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 79 (S.D.N.Y. Aug. 4, 2023)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 80 (S.D.N.Y. Aug. 4, 2023)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 80 (S.D.N.Y. Aug. 4, 2023)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 78 (S.D.N.Y. Aug. 1, 2023)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 78 (S.D.N.Y. Aug. 1, 2023)
+ More Snippets
Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 325 (D.Del. May. 20, 2024)
Cite Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 325 (D.Del. May. 20, 2024)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 55 (S.D.N.Y. Nov. 16, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 55 (S.D.N.Y. Nov. 16, 2022)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 56 (S.D.N.Y. Nov. 16, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 56 (S.D.N.Y. Nov. 16, 2022)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 53 (S.D.N.Y. Nov. 16, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 53 (S.D.N.Y. Nov. 16, 2022)
+ More Snippets
Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 303 (D.Del. May. 1, 2024)
Cite Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 303 (D.Del. May. 1, 2024)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 52 (S.D.N.Y. Nov. 2, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 52 (S.D.N.Y. Nov. 2, 2022)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 47 (S.D.N.Y. Nov. 1, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 47 (S.D.N.Y. Nov. 1, 2022)
+ More Snippets
Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 291 (D.Del. Apr. 26, 2024)
Cite Document
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al, 1:22-cv-00252, No. 291 (D.Del. Apr. 26, 2024)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 46 (S.D.N.Y. Oct. 4, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 46 (S.D.N.Y. Oct. 4, 2022)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 43 (S.D.N.Y. Oct. 4, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 43 (S.D.N.Y. Oct. 4, 2022)
+ More Snippets
Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 42 (S.D.N.Y. Sep. 6, 2022)
Cite Document
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al, 1:22-cv-02229, No. 42 (S.D.N.Y. Sep. 6, 2022)
+ More Snippets